1
/
of
2
Bexsero (Meningococcal rDNA, absorbed) for IM Injection
Bexsero (Meningococcal rDNA, absorbed) for IM Injection
Regular price
₱8,500.00 PHP
Regular price
Sale price
₱8,500.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Bexsero (Meningococcal B Vaccine) for IM Injection is a recombinant meningococcal serogroup B conjugate vaccine formulated with four key antigens: NHBA, NadA, fHbp, and NZ98/254 strain. Designed to protect against invasive meningococcal disease caused by serogroup B, this FDA-approved vaccine is indicated for individuals 10 years and older.
Clinical evidence supports 85–100% effectiveness for a minimum of two years post-vaccination. The vaccine works by stimulating antibody production against meningococcal polysaccharide capsules, providing robust immune protection.
Bexsero is recommended as part of routine adolescent immunization schedules, with primary administration at ages 11–12 and a booster at 16 years. Healthcare providers prioritize this vaccine for at-risk populations, including college students, military recruits, individuals with asplenia, and those with complement system deficiencies.
Administration requires qualified healthcare professionals in clinical or hospital settings. Each intramuscular injection delivers optimal immunogenicity when stored and handled according to manufacturer specifications. Bexsero may be administered during the same visit as other vaccines to ensure comprehensive serogroup B coverage and streamline immunization protocols.
Clinical evidence supports 85–100% effectiveness for a minimum of two years post-vaccination. The vaccine works by stimulating antibody production against meningococcal polysaccharide capsules, providing robust immune protection.
Bexsero is recommended as part of routine adolescent immunization schedules, with primary administration at ages 11–12 and a booster at 16 years. Healthcare providers prioritize this vaccine for at-risk populations, including college students, military recruits, individuals with asplenia, and those with complement system deficiencies.
Administration requires qualified healthcare professionals in clinical or hospital settings. Each intramuscular injection delivers optimal immunogenicity when stored and handled according to manufacturer specifications. Bexsero may be administered during the same visit as other vaccines to ensure comprehensive serogroup B coverage and streamline immunization protocols.
Share
